Picture of Penumbra logo

PEN Penumbra Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Annual cashflow statement for Penumbra, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2021
December 31st
2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line2.62-29114178
Depreciation
Deferred Taxes
Non-Cash Items71.342.177.317165.2
Unusual Items
Purchased R&D
Other Non-Cash Items
Changes in Working Capital-66.7-122-79.1-23.8-42.7
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Net Change in Other Assets & Liabilities
Cash from Operating Activities9.5-55.797.3168239
Capital Expenditures-21.2-19.3-15.2-21.2-63.7
Purchase of Fixed Assets
Other Investing Cash Flow Items-0.55574.1-0.86398.8-341
Acquisition of Business
Sale of Business
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-21.754.8-16.177.6-405
Financing Cash Flow Items-16.1-8.18-2.23-1.52-2.8
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities0.83611.616.2-8726.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-10.310.597.6157-138